Rivaroxaban for oral suspension, 1 mg/ml (RLD Xarelto) had a market value of roughly $11 million, per IQVIA July 2025 data.

Bayer AG’s BAYRY wholly owned, independently operated subsidiary BlueRock Therapeutics LP announced positive 36-month data ...

An appeals court decision striking down claims from a patent for a blockbuster drug that rested on language touting its ...

NEW ORLEANS (AP) — The pharmaceutical companies behind the widely advertised blood thinner Xarelto reached a $775 million settlement in 25,000 lawsuits alleging patients were not adequately warned ...

Bayer and Johnson & Johnson have successfully defended the safety of their big-selling clotbuster Xarelto in court, but as the case count continues to climb, the companies have agreed to shell out ...

LONDON (Reuters) - Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker. The company's blockbuster Xarelto ...

At last year’s European Society of Cardiology annual meeting, Johnson & Johnson was touting data that put its clot-busting Xarelto on track for a new approval worth $1 billion-plus. Not so this year.

Bayer BAYRY, along with San Diego, CA-based, privately held company, Kumquat Biosciences, announced the initiation of a phase ...

Johnson & Johnson and Bayer, who jointly sell the blood thinner drug Xarelto, settled lawsuits that claimed the companies failed to warn about potentially fatal side-effects for $775 million; the ...

RARITAN, N.J., May 16, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO ® (rivaroxaban) ...

Janssen announced that the Food and Drug Administration (FDA) has approved Xarelto (rivaroxaban) to reduce the risk of major cardiovascular (CV) events, such as CV death, myocardial infarction (MI) ...

Medicare Part D and Medicare Advantage plans with prescription drug coverage may cover Xarelto if it appears on the plan’s formulary. There are currently no generic alternatives available for Xarelto, ...